ILA 28.6% 13.5¢ island pharmaceuticals limited

Ann: ISLA-101 Phase 2a clinical trial update, page-43

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 67 Posts.
    lightbulb Created with Sketch. 1
    My bad. It should be around Jan 2023 according to recent report Q2 2023 the trial should commence with patient screening and enrollment.
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.